Zhang T, Lin H, Ren Y, Yang Z, Wang J, Duan X, et al
GSK says essentially the same thingthat Arexvy is covered for nearly all adults over 60 years of age, and those patients will pay $0 out of pocket thanks to the Inflation Reduction Act
Why Insurance Exclusion Doesnt Matter Paradoxically, insurance not covering compounded semaglutide isnt a problem because the out-of-pocket price ($199 monthly) is typically lower than brand-name copays with insurance
The result is a faster transition through each healing phase and higher-quality repair, particularly for tissues with poor native blood supply like tendons, ligaments, and cartilage
Access is currently limited to approved clinical trials